Skip to content
Wenlo
Sign in
← Markets

Natera, Inc.

Solomon Moshkevich (PRESIDENT, CLINICALDIAGNOSTICS) sells NTRA shares

4NTRAFiled Oct 29, 2026, 9:35 PM ET· Period Oct 27, 2026

AI-generated summary

Solomon Moshkevich, PRESIDENT, CLINICALDIAGNOSTICS of Natera, Inc., sold 2,172 shares of Common Stock in open-market sales at an average price of $416.88 for a total value of $905,467.54. The transactions took place on October 27, 2026 and October 28, 2026 under a Rule 10b5-1 trading plan. After the sales, the insider directly held 104,742 shares of Common Stock.

View original filing on SEC.gov (opens SEC EDGAR)

Key facts

Insider
Solomon Moshkevich · PRESIDENT, CLINICALDIAGNOSTICS

Rule 10b5-1 plan

DateTransactionSharesPriceValueHeld afterOwnership
Oct 27, 2026S · open-market saleFootnotes F1−1,010$406.00$410,060.00105,904Direct
Oct 28, 2026S · open-market saleFootnotes F2−1,162$426.34$495,407.54104,742Direct
Footnotes
  1. F1 The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units ("RSUs") and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 26, 2024.
  2. F2 The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 27, 2023.

More NTRA filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.